Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nightly antibiotic prophylaxis versus clinical surveillance in children with primary high-grade vesicoureteral reflux
2007-006253-60Phase 4Active
- Sponsor
- MAR ESPINO HERNANDEZ
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefadroxil, fosfomycin, trimethoprim, trimethoprim + sulfamethoxazole and amoxicillin in vesicoureteral reflux (VUR) (2 arms), sponsored by MAR ESPINO HERNANDEZ. Primary endpoints: Acute renal involvement on DMSA scintigraphy and Incidence of renal damage or scarring. Started Mar 2010; status: active.
02
Drugs
cefadroxilfosfomycintrimethoprimtrimethoprim + sulfamethoxazoleamoxicillin
03
Conditions
vesicoureteral reflux (VUR)
Beyond the preview
Go deeper on 2007-006253-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006253-60.